New pain relief combo tested for wrist surgery recovery
NCT ID NCT06235606
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different methods to control pain after wrist fracture surgery. One group received a long-lasting numbing medicine (liposomal bupivacaine) plus standard bupivacaine, while the other group received a sedative (dexmedetomidine) plus standard bupivacaine. The goal was to see which approach provides better pain relief and helps patients recover faster. 96 adults undergoing wrist fracture repair took part in this completed Phase 3 trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Hong Kong
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single nerve block slash opioid use in Children's elbow surgery?
- Your genes may hold the key to predicting Post-Surgical pain
- Unlocking the mystery of persistent pain after breast surgery
- Could a pill replace a needle for emergency pain relief?
- A simple fan could cool away IV needle pain
- Can a smartphone VR headset distract kids from burn pain?